Performance Comparison of QuantiFERON Monitor in Solid Organ Transplant Recipients
NCT ID: NCT02416414
Last Updated: 2016-03-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
166 participants
OBSERVATIONAL
2015-07-31
2016-02-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Functional Non Specific Immunity Monitoring After Kidney Transplantation Using an Interferon Gamma Test
NCT03572842
Technology Enabled And Molecular Monitoring of the Allograft and Transplant rEcipient
NCT05033548
Pilot Study to Assess Safety and Feasibility of Normothermic Machine Preservation In Human Liver Transplantation
NCT02515708
A Retrospective Multicenter Study to Determine 5-Year Clinical Outcomes in Subjects Previously Enrolled in the CTOT-01 Study
NCT01974999
Deep Phenotyping of the Renal Allograft to Prognosticate Clinical Outcomes
NCT06438107
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Solid Organ Transplant Recipients
Subjects who have received a Solid Organ Transplant.
QuantiFERON Monitor Assay
Assay to measure cell-mediated immune function using QuantiFERON Monitor assay.
Existing methodology
Assay to measure cell-mediated immune function using existing methodology.
Healthy Controls
Healthy individuals.
QuantiFERON Monitor Assay
Assay to measure cell-mediated immune function using QuantiFERON Monitor assay.
Existing methodology
Assay to measure cell-mediated immune function using existing methodology.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
QuantiFERON Monitor Assay
Assay to measure cell-mediated immune function using QuantiFERON Monitor assay.
Existing methodology
Assay to measure cell-mediated immune function using existing methodology.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Received a solid organ transplant
* Provide Informed Consent
Exclusion Criteria
* Treatment of Rejection
Healthy Control
* Currently taking any immunomodulatory medication
* A history of immunosuppressive disease or immunosuppression condition or history of autoimmune diseases
* Current pregnancy or recent lactation (\<1yr)
* Currently taking antiviral medication
* Currently being treated for infectious diseases
18 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
QIAGEN Gaithersburg, Inc
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Camille N Kotton, M.D.
Role: PRINCIPAL_INVESTIGATOR
Transplant and Immunocompromised Host Infectious Diseases
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of California Los Angeles
Los Angeles, California, United States
Massachusetts General Hospital
Boston, Massachusetts, United States
The Cleveland Clinic Foundation
Cleveland, Ohio, United States
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CST007_10
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.